Tilfælde af hepatitis (alvorlig og livstruende hepatoksicitet, inkl. fatal fulminant hepatitis) er blevet rapporteret for patienter behandlet med VIRAMUNE.
Cases of hepatitis (severe and life-threatening hepatoxicity, including fatal fulminant hepatitis) have been reported in patients treated with VIRAMUNE.